Amneal Pharmaceuticals, Inc.
AMRX· Nasdaq
AMRXAmneal Pharmaceuticals, Inc.
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001723128-18-000013
| Metric | Q1 2018 | Q1 2017 |
|---|---|---|
| Revenue | $275.19M | $225.68M |
| Net Income | $0.00 | $42.26M |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
